苏格兰高胆固醇血症和高血压处方发生率的人群研究：医疗系统是否从COVID-19影响中恢复？

数据集获取（Figshare）

• 源站标题：A population-based study of incident prescribing for hypercholesterolaemia and hypertension in Scotland: is the healthcare system recovering from the impact of COVID-19?
• DOI：10.6084/m9.figshare.28631339.v1
• 发布日期：2025-03-20
• 文件数：2 个
• 文件总体积：494.14 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/A_population-based_study_of_incident_prescribing_for_hypercholesterolaemia_and_hypertension_in_Scotland_is_the_healthcare_system_recovering_from_the_impact_of_COVID-19_/28631339

命令行下载

curl -L -o "icmo_a_2482674_sm0907.docx" "https://ndownloader.figshare.com/files/53124557"
curl -L -o "icmo_a_2482674_sm0906.docx" "https://ndownloader.figshare.com/files/53124560"

文件清单

• icmo_a_2482674_sm0907.docx（326.96 KB）
• icmo_a_2482674_sm0906.docx（167.18 KB）

文件总体积 494.14 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

COVID-19 pandemic caused significant disruptions in healthcare services, with previous studies estimated that the early months of the pandemic led to a substantial decline in new prescriptions for hypercholesterolemia and hypertension. The long-term recovery of healthcare systems in addressing these gaps remains uncertain. We aimed to assess the recovery of the healthcare system in Scotland regarding the initiation of treatments for hypercholesterolemia and hypertension post-COVID-19 pandemic.
This retrospective cohort study analysed prescription data from January 2020 to December 2022 in Scotland, as well as In-hours encounters with general practitioners. Incident prescribing patterns for drugs used in the treatment of hypercholesterolemia and hypertension were compared against pre-pandemic averages from 2018 to 2019. Data were stratified by health regions and socioeconomic status.
New treatment initiations for drugs used in the treatment of hypercholesterolemia and hypertension significantly increased from mid-2021 onwards, surpassing pre-pandemic levels. By December 2022, there were approximately 40,000 and 60,000 additional new treatments for drugs used to treat hypercholesterolemia and hypertension, respectively, compared to the expected numbers based on 2018–2019 averages. The stratified analysis showed a relatively higher increase in less deprived quintiles. GP encounter activities mirrored trends in new antihypertensive and lipid-lowering initiations, with a significant reduction starting in March 2020 due to the first COVID-19 lockdown. Encounter rates gradually recovered from May 2020, reaching near pre-pandemic levels by March 2021. Notably, the encounter rate slopes during the reference period (2018–2019) and post-recovery phase (May 2021–December 2022) showed no significant difference [–0.7 (95% CI: −4.0, 2.5) vs. 0.9 (95% CI: −3.1, 4.9)].
The observed increase in new treatments for drugs to treat hypercholesterolemia and hypertension suggests recovery of the healthcare system in Scotland following the COVID-19 pandemic. These higher prescribing rates post-pandemic hypothesise potential long-term sequelae associated with COVID-19. The findings de

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.28631339.v1（source: https://tandf.figshare.com/articles/dataset/A_population-based_study_of_incident_prescribing_for_hypercholesterolaemia_and_hypertension_in_Scotland_is_the_healthcare_system_recovering_from_the_impact_of_COVID-19_/28631339）。